LIAISON VZV IgG HT, LIAISON Control VZV IgG HT— 510(k) K231214

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K231214 for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT, Substantially Equivalent on 2023-10-27. Applicant: DiaSorin, Inc..

Clearance details

Applicant
DiaSorin, Inc.
Product code
Code LFY
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Stillwater, MN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.